HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A new concept: Aβ1-42 generates a hyperfunctional proteolytic NCX3 fragment that delays caspase-12 activation and neuronal death.

Abstract
Although the amyloid-β(1-42) (Aβ(1-42)) peptide involved in Alzheimer's disease is known to cause a dysregulation of intracellular Ca(2+) homeostasis, its molecular mechanisms still remain unclear. We report that the extracellular-dependent early increase (30 min) in intracellular calcium concentration ([Ca(2+)](i)), following Aβ(1-42) exposure, caused the activation of calpain that in turn elicited a cleavage of the Na(+)/Ca(2+) exchanger isoform NCX3. This cleavage generated a hyperfunctional form of the antiporter and increased NCX currents (I(NCX)) in the reverse mode of operation. Interestingly, this NCX3 calpain-dependent cleavage was essential for the Aβ(1-42)-dependent I(NCX) increase. Indeed, the calpain inhibitor calpeptin and the removal of the calpain-cleavage recognition sequence, via site-directed mutagenesis, abolished this effect. Moreover, the enhanced NCX3 activity was paralleled by an increased Ca(2+) content in the endoplasmic reticulum (ER) stores. Remarkably, the silencing in PC-12 cells or the knocking-out in mice of the ncx3 gene prevented the enhancement of both I(NCX) and Ca(2+) content in ER stores, suggesting that NCX3 was involved in the increase of ER Ca(2+) content stimulated by Aβ(1-42). By contrast, in the late phase (72 h), when the NCX3 proteolytic cleavage abruptly ceased, the occurrence of a parallel reduction in ER Ca(2+) content triggered ER stress, as revealed by caspase-12 activation. Concomitantly, the late increase in [Ca(2+)](i) coincided with neuronal death. Interestingly, NCX3 silencing caused an earlier activation of Aβ(1-42)-induced caspase-12. Indeed, in NCX3-silenced neurons, Aβ(1-42) exposure hastened caspase-dependent apoptosis, thus reinforcing neuronal cell death. These results suggest that Aβ(1-42), through Ca(2+)-dependent calpain activation, generates a hyperfunctional form of NCX3 that, by increasing Ca(2+) content into ER, delays caspase-12 activation and thus neuronal death.
AuthorsAnna Pannaccione, Agnese Secondo, Pasquale Molinaro, Carla D'Avanzo, Maria Cantile, Alba Esposito, Francesca Boscia, Antonella Scorziello, Rossana Sirabella, Sophie Sokolow, André Herchuelz, Gianfranco Di Renzo, Lucio Annunziato
JournalThe Journal of neuroscience : the official journal of the Society for Neuroscience (J Neurosci) Vol. 32 Issue 31 Pg. 10609-17 (Aug 01 2012) ISSN: 1529-2401 [Electronic] United States
PMID22855810 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • Calcium Channel Blockers
  • Chelating Agents
  • Peptide Fragments
  • Slc8a3 protein, mouse
  • Sodium-Calcium Exchanger
  • amyloid beta-protein (1-42)
  • sodium-calcium exchanger 1
  • Egtazic Acid
  • Nerve Growth Factor
  • Sodium
  • Calpain
  • Caspase 3
  • Calcium
Topics
  • Amyloid beta-Peptides (pharmacology)
  • Animals
  • Calcium (metabolism)
  • Calcium Channel Blockers (pharmacology)
  • Calpain (metabolism)
  • Caspase 3 (metabolism)
  • Cell Death (drug effects, genetics)
  • Cell Differentiation (drug effects)
  • Cells, Cultured
  • Chelating Agents (pharmacology)
  • Cricetinae
  • Dogs
  • Dose-Response Relationship, Drug
  • Egtazic Acid (pharmacology)
  • Embryo, Mammalian
  • Endoplasmic Reticulum (drug effects)
  • Enzyme Activation (drug effects)
  • Female
  • Hippocampus (cytology)
  • Male
  • Mice
  • Mice, Knockout
  • Nerve Growth Factor (pharmacology)
  • Neurons (drug effects)
  • Patch-Clamp Techniques
  • Peptide Fragments (pharmacology)
  • Proteolysis (drug effects)
  • RNA Interference (physiology)
  • Rats
  • Sodium (metabolism)
  • Sodium-Calcium Exchanger (genetics, metabolism)
  • Time Factors
  • Transfection
  • Up-Regulation (drug effects, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: